Christina C. Gyenge, P.h.D, guides us through the systematic design and development of electrocatalysts for Agora’s CO2 redox ...
Phase I trials are conducted to provide initial indications about the safety of therapeutic interventions and, in the case of drugs, their pharmacodynamic and, pharmacokinetic properties. They involve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results